# Bacteriophage Therapy in Patients With Prosthetic Joint Infections

> **NCT04787250** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Adaptive Phage Therapeutics, Inc.**

## Conditions studied

- Prosthetic Joint Infection

## Interventions

- **BIOLOGICAL:** Phage Therapy
- **PROCEDURE:** Two-Stage Exchange Arthroplasty

## Key facts

- **NCT ID:** NCT04787250
- **Lead sponsor:** Adaptive Phage Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-10
- **Primary completion:** 2023-05
- **Final completion:** 2024-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Changes to protocol design
- **Last updated:** 2022-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04787250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04787250, "Bacteriophage Therapy in Patients With Prosthetic Joint Infections". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04787250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*